Drug Type Small molecule drug |
Synonyms 二甲啡烷磷酸盐, 磷酸二甲啡烷, AT-17 + [2] |
Target |
Action agonists |
Mechanism σ1 receptor agonists(Sigma opioid receptor agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseApproved |
First Approval Date Japan (24 May 1974), |
Regulation- |
Molecular FormulaC18H28NO4P |
InChIKeyODJHDWLIOUGPPA-URVXVIKDSA-N |
CAS Registry36304-84-4 |
| KEGG | Wiki | ATC | Drug Bank |
|---|---|---|---|
| - | Dimemorfan Phosphate |
| Indication | Country/Location | Organization | Date |
|---|---|---|---|
| Cough | Japan | 24 May 1974 |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Acute Bronchitis | Phase 3 | China | 10 Nov 2016 | |
| Acute upper respiratory infection | Phase 3 | China | 10 Nov 2016 | |
| Pneumonia | Phase 3 | China | 10 Nov 2016 | |
| Dry cough | Phase 3 | China | 19 Sep 2013 |





